These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8842981)

  • 1. Radioimmunoassay of Antarelix, a luteinizing hormone releasing-hormone antagonist, in plasma and its application for pharmacokinetic study in dogs.
    Sorensen S; Rondeau JJ; Lenaerts V; Boutignon F; Wüthrich P; Deghenghi R; Adam A; Ong H
    J Immunoassay; 1996 Aug; 17(3):205-26. PubMed ID: 8842981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans study.
    Erb K; Pechstein B; Schueler A; Engel J; Hermann R
    Clin Pharmacol Ther; 2000 Jun; 67(6):660-9. PubMed ID: 10872648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay of [D-Trp6]-luteinizing hormone-releasing hormone: its application to animal pharmacokinetic studies after single injection and long-acting formulation administration.
    Ezan E; Drieu K; Chapelat M; Rougeot C; Dray F
    Regul Pept; 1986 Apr; 14(2):155-67. PubMed ID: 2940625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay of detirelix ([ N-Ac-D-Nal(2)1,D-p-Cl-Phe2,D-Trp3, D-hArg(Et)6(2),D-Ala10]-luteinizing hormone-releasing hormone) in plasma or serum.
    Nerenberg C; LaFargue J; Webb A; Chan R; Kushinsky S
    J Immunoassay; 1988; 9(3-4):245-55. PubMed ID: 3069871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of radioimmunoassay for a potent luteinizing hormone-releasing hormone antagonist. Evaluation of serum levels after injection of [Ac-3-(2-naphthyl)-D-Ala1, D-Phe(pCl)2, 3-(3-pyridyl)-D-Ala3, D-Cit6, D-Ala10] LHRH.
    Csernus VJ; Szende B; Groot K; Redding TW; Schally AV
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):111-8. PubMed ID: 2110458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of the developmental competence of sheep oocytes by inhibition of LH pulses during the follicular phase with a GnRH antagonist.
    Oussaid B; Mariana JC; Poulin N; Fontaine J; Lonergan P; Beckers JF; Cognie Y
    J Reprod Fertil; 1999 Sep; 117(1):71-7. PubMed ID: 10645247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin release in periovulatory heifers after GnRH analogs measured by two types of immunoassays.
    Schneider F; Bellmann A; Becker F; Bambang Poernomo S; Rehfeldt C; Nürnberg G; Kanitz W
    Exp Clin Endocrinol Diabetes; 2002 Aug; 110(5):235-44. PubMed ID: 12148088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of GnRH and its antagonist (Antarelix) on LH release from cultured bovine anterior pituitary cells.
    Bellmann A; Schneider F; Kanitz W; Nürnberg G; Tiemann U
    Acta Vet Hung; 2002; 50(1):79-92. PubMed ID: 12061239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay of meterelin and pharmacokinetics after single injection and implant administration in dogs.
    Hudon E; Rondeau JJ; Lenaerts V; Würthrich P; Boutignon F; Deghenghi R; Marleau S; Yamaguchi N; Adam A; Ong H
    J Pharm Sci; 1997 Feb; 86(2):172-8. PubMed ID: 9040091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassay of nafarelin ([ 6-(3-(2-naphthyl)-D-alanine)]-luteinizing hormone-releasing hormone) in plasma or serum.
    Nerenberg C; Foreman J; Chu N; Chaplin MD; Kushinsky S
    Anal Biochem; 1984 Aug; 141(1):10-6. PubMed ID: 6238549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-finding study of daily gonadotropin-releasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF/ICSI patients: antide and hormone levels.
    Huirne JA; van Loenen AC; Schats R; McDonnell J; Hompes PG; Schoemaker J; Homburg R; Lambalk CB
    Hum Reprod; 2004 Oct; 19(10):2206-15. PubMed ID: 15333605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antarelix (EP 24332) a novel water soluble LHRH antagonist.
    Deghenghi R; Boutignon F; Wüthrich P; Lenaerts V
    Biomed Pharmacother; 1993; 47(2-3):107-10. PubMed ID: 7693007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the Booroola Fec gene on ovarian follicular populations in superovulated Romanov ewes pretreated with a GnRH antagonist.
    Dufour JJ; Cognié Y; Mermillod P; Mariana JC; Romain RF
    J Reprod Fertil; 2000 Jan; 118(1):85-94. PubMed ID: 10793629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid microparticles as sustained release system for a GnRH antagonist (Antide).
    Del Curto MD; Chicco D; D'Antonio M; Ciolli V; Dannan H; D'Urso S; Neuteboom B; Pompili S; Schiesaro S; Esposito P
    J Control Release; 2003 Apr; 89(2):297-310. PubMed ID: 12711452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay of ganirelix in plasma or serum.
    Nerenberg C; LaFargue J; Gee C; Chu F; Wolfe L; Chan R; Tarnowski T
    J Immunoassay; 1993 Sep; 14(3):191-207. PubMed ID: 8354719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunoassay for hexarelin, a peptidic growth hormone secretagogue, and its pharmacokinetic studies.
    Roumi M; Lenaerts V; Boutignon F; Wuthrich P; Deghenghi R; Bellemare M; Adam A; Ong H
    Peptides; 1995; 16(7):1301-6. PubMed ID: 8545255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge.
    Fraser HM; Lunn SF; Morris KD; Deghenghi R
    Hum Reprod; 1997 Mar; 12(3):430-5. PubMed ID: 9130734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gonadotrophin deprivation on follicular growth in gilts.
    Driancourt MA; Locatelli A; Prunier A
    Reprod Nutr Dev; 1995; 35(6):663-73. PubMed ID: 8534360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteinizing hormone--releasing hormone levels in human plasma: a radioimmunoassay method.
    Aksel S; Glass R
    Am J Obstet Gynecol; 1979 Jul; 134(6):619-23. PubMed ID: 380341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation in rat plasma of a direct radioimmunoassay for a luteinizing hormone-releasing hormone antagonist (BIM 21009).
    Ezan E; Drieu K; Moreau JP; Dray F
    J Immunoassay; 1990; 11(3):295-309. PubMed ID: 2229420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.